| Chagas is global: Manuel Gutiérrez Torrico tells the creation of FINDECHAGAS [April 21, 2012] | |
Interview of Manuel Gutiérrez Torrico, former President of FINDECHAGAS. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| FindeChagas : Chagas Day [April 14, 2012] | |
Interview of Eric Stobbaerts, Head of Regional Office, DNDi Latin Americai. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| Argentina launches benznidazole [April 4, 2012] | |
Interview of Bernard Pécoul, DNDi Executive Director (March 20, 2012)i. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| Drug development pipeline for Human African Trypanosomiasis (HAT) [March 12, 2012] | |
Interview of Dr. Nahtalie Strub Wourgaft, Medical Director at DNDi. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| Registration of paramomycin in Uganda (VL) [March 12, 2012] | |
| |
To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts |
Professor El Hassan on DNDi and the LEAP platform’s efforts to strengthen Sudan’s capacity to combat VL [January 30, 2012] | |
Professor El Hassan from the Institute of Endemic Diseases, University of Khartoum, explains how DNDi and the LEAP platform have endeavoured over nearly a decade to bring change through capacity strengthening to the management and treatment of VL in Sudan To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| Major Project launched to Support India and Bangladesh's National Control Programmes in Implementing New Treatments to Boost Kala-Azar Elimination Strategies [November 07, 2011] | |
Interview with consortium partners: Dr. Bhawna Sharma (Head of DNDi India), Sally Ellis (Clinical Manager, DNDi), Dr. Philippe Desjeux (Senior Programme Officer, OWH), and Dr. Byron Arana (Scientist, TDR) To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| DNDi collaborates closely with neglected disease-endemic countries [November 07, 2011] | |
Carlos Morel, Director of the Centre for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil, gives his perspective on DNDi's specificities as an organization embedded in neglected disease-endemic countries. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts | |
| Leishmaniasis East Africa Platform (LEAP) creating change for clinical researchers [September 30, 2011] | |
| |
To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts |
| The expansion of DNDi's portfolio into paediatric HIV and helminth infections [July 18, 2011] | |
![]() | Bernard Pécoul, Executive Director of DNDi, speaks about the expansion of DNDi’s portfolio into paediatric HIV and helminth infections. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts |
| DNDi launches new drugs development programmes to address treatment needs of children with HIV/AIDS [July 18, 2011] | |
![]() | Marc Lallemant, Head of HIV Programme, speaks about paediatric HIV and DNDi's strategy for paediatric HIV. To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts |
| New potential oral drug for sleeping sickness [28 June 2011] | |
![]() | Bernard Pécoul, Executive Director of DNDi, speaks about DNDi and the biotech partnership with Anacor and SCYNEXIS for a new potential oral treatment for sleeping sickness at a press conference in Washington DC To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts |